The government isn’t particularly interested in making sure Americans know what they’re eating. It seems like knowing what is in the food should be a basic right, but that doesn’t seem to be the case. In fact, last week Congress passed a federal requirement for labeling products containing genetically modified ingredients that signifies a big win for food companies.
U.S. regulators in July of 2016 halted a trial of Juno Therapeutics Inc.’s experimental cancer therapy, known as JCAR015, after three patients died.
JCAR015 uses genetically engineered cells as a treatment for cancer. However, one of the pursuits in oncology was temporarily halted by the FDA when some of the participants developed fatal swelling in the brain.
Hans Bishop, Juno’s chief executive, said in a conference call with securities analysts that the deaths were “difficult and humbling for everyone involved.”
A Penn State University researcher has created a genetically modified mushroom that is now at the center of controversy over GMO regulations of genetically modified creations.
Thousands of comments have been filed with the Food and Drug Administration (FDA) since November 12, 2015 for its ‘open comment’ period on the ‘natural’ foods label.
On Monday and Tuesday, 150 members of the European Parliament (MEP) donated urine samples to find out if they have glyphosate in their systems. The screening comes ahead of a symbolic vote in the European Union that is scheduled for Wednesday, April 12, on whether to re-license the RoundUp chemical for another 15 years. [1]
Researchers in China claim they have successfully added mutations to human embryos which make them HIV-proof.
Before you pop open a bottle of California Merlot, there is something you should know: trace amounts of glyphosate, the primary toxic chemical found in Monsanto’s Roundup herbicide, have been found in 100% of California wines tested by the national GMO awareness group, Moms Against Monsanto.
The news comes on the heels of a report finding 14 brands of beers tested positive for the likely carcinogen in Germany.
Biotech giant Monsanto reported multiple profit-plummets in 2015 relating to sales for both its genetically modified crop creations and its best-selling herbicide, Roundup. Once again, Monsanto has reported declining profits for the fiscal second-quarter earnings – by 25%.
Monsanto’s Kenya Ltd., a subsidiary of the larger company, is trying to push another genetically modified Bt cotton strain into Africa. Representatives have submitted an application to release GM cotton seed known as MON 15985, or Bollgard II. [1]
The Food and Drug Administration (FDA) is facing a lawsuit filed by nearly a dozen fishing and environmental groups that are trying to block the agency’s recent approval of genetically modified salmon.
